Lactose/Galactose Assay Kit (Rapid) (Bottle 5)

Megazyme

Revision date : 2022-03-14

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS08
Health risk rating 5
Safety risk rating 4
Environmental risk rating 1

General Information

Version

1.3

Revision date

2022-03-14

Product name

Lactose/Galactose Assay Kit (Rapid) (Bottle 5)

1.2.1 Relevant identified uses

Industrial/Professional use spec

Emergency telephone

+353 12861220

Icons in SDS

M004 M009 M010 M011 GHS08

Company Information

company name

Megazyme

e-mail address of the competent person responsible for the Safety Data Sheet

cs@megazyme.com

Hazard Codes

Hazard statements (CLP)

H334

Hazard statements

Code

Statements

H334

May cause allergy or asthma symptoms or breathing difficulties if inhaled

Section 2

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

May cause allergy or asthma symptoms or breathing difficulties if inhaled

Supplemental label elements

EUH032 - Contact with acids liberates very toxic gas. EUH208 - Contains Epimerase, aldose 1-, Galactose mutarotase. May produce an allergic reaction. EUH210 - Safety data sheet available on request. Labelling according to: exemption for inner packaging where the contents do not exceed 10ml No labelling required

2.3 Other hazards

Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Not classified Adverse physicochemical, human health and environmental effects May cause allergy or asthma symptoms or breathing difficulties if inhaled.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.